SELLAS Life Sciences Group, Inc. (SLS)
11.98
+1.49
(+14.20%)
USD |
NASDAQ |
Oct 20, 16:00
12.09
+0.11
(+0.92%)
After-Hours: 07:25
SELLAS Life Sciences Group Gross Profit (TTM) : 0.00 for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -0.158M |
| December 31, 2023 | -0.245M |
| September 30, 2023 | -0.368M |
| June 30, 2023 | -0.575M |
| March 31, 2023 | -0.499M |
| December 31, 2022 | 0.443M |
| September 30, 2022 | -0.707M |
| June 30, 2022 | -0.50M |
| March 31, 2022 | 1.382M |
| December 31, 2021 | 5.281M |
| September 30, 2021 | 8.377M |
| June 30, 2021 | 8.277M |
| March 31, 2021 | 6.377M |
| December 31, 2020 | 1.523M |
| September 30, 2020 | -0.30M |
| June 30, 2020 | -0.30M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.30M |
| December 31, 2019 | -0.30M |
| September 30, 2019 | -0.30M |
| June 30, 2019 | -0.20M |
| March 31, 2019 | -0.10M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.598M |
| March 31, 2017 | -1.302M |
| December 31, 2016 | -1.375M |
| September 30, 2016 | -1.426M |
| June 30, 2016 | -0.828M |
| March 31, 2016 | 2.348M |
| December 31, 2015 | 4.632M |
| September 30, 2015 | 7.219M |
| June 30, 2015 | 8.522M |
| March 31, 2015 | 7.936M |
| December 31, 2014 | 7.476M |
| September 30, 2014 | 5.907M |
| June 30, 2014 | 5.473M |
| March 31, 2014 | 3.548M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| AbbVie, Inc. | 45.98B |
| ImmunityBio, Inc. | 148.09M |
| TG Therapeutics, Inc. | 658.60M |
| Capricor Therapeutics, Inc. | -2.095M |
| Relay Therapeutics, Inc. | 8.139M |